EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for CALC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -2.237
March 31, 2026 1.524
December 31, 2025 -3.485
September 30, 2025 -2.588
June 30, 2025 -1.986
March 31, 2025 -1.785
December 31, 2024 -1.668
September 30, 2024 -2.523
June 30, 2024 -1.776
March 31, 2024 0.0647
December 31, 2023 -3.602
September 30, 2023 -4.075
June 30, 2023 -5.567
March 31, 2023 -117.17
Date Value
December 31, 2022 82.34
September 30, 2022 -2172.72
June 30, 2022 -2557.79
March 31, 2022 -3229.62
December 31, 2021 -28.43
September 30, 2021 -26.27
June 30, 2021 -25.51
March 31, 2021 -38.13
December 31, 2020 -30.54
September 30, 2020 -24.72
June 30, 2020 -32.55
March 31, 2020 -31.61
December 31, 2019 -44.14
September 30, 2019 -42.60

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 2.268
Eli Lilly & Co. 7.939

EPS Diluted (Quarterly) Related Metrics